Atlas Trials

Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma

Clinical trial NCT01719302 · COMPLETED

Trial details

NCT number
NCT01719302
Sponsor
University of Vermont
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Stage III Adult Soft Tissue Sarcoma
Start date
2012-10-01
Primary completion
2015-04-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.